Great Bay Bio
PrivateLast Round
Series B
Dec 16, 2024
Total Funding Raised
$28.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Great Bay Bio is a biotechnology company that develops AI-driven bioprocessing technology to accelerate biologic drug discovery, cell line engineering, and manufacturing preparation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Great Bay Bio Comparables
Compare Great Bay Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chime Biologics | 83% | |
| Enzene Biosciences | 78% | |
| GenScript | 77% |
Great Bay Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 16, 2024 | ||||
| Series B | Sep 13, 2022 | ||||
| Series A | Dec 1, 2021 | ||||
| Convertible Debt | Feb 23, 2021 |
Key People
Founding team and executive leadership
Great Bay Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vectr Ventures | Series B |
| Tiger Jade Capital | Series B |
| FutureX Capital | Series A |
| Pentepebble | Series B |
| 高瓴创投 | Series A |
| Proxima Ventures Ltd. | Series A |
| Gobi Partners GBA | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 132% MoM, reaching 1.8K.
- Jun 17, 2026
Monthly visitors increased 62% MoM.
Great Bay Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Great Bay Bio's valuation, stock price, and market status.
Is Great Bay Bio a public or private company?
Great Bay Bio is a private company.
What is the current stock price of Great Bay Bio?
Great Bay Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Great Bay Bio worth (valuation)?
Valuation information for Great Bay Bio is not publicly available.
Can I buy Great Bay Bio stock?
Great Bay Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Great Bay Bio's last funding round?
Great Bay Bio's most recent funding round was Series B on December 16, 2024.
Who are the main investors in Great Bay Bio?
Key investors in Great Bay Bio include Tiger Jade Capital, Proxima Ventures Ltd..
Will Great Bay Bio IPO soon?
No public IPO plans have been announced for Great Bay Bio.
How can I track Great Bay Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Great Bay Bio's secondary market activity and sign up for updates.